I Caraballo
Overview
Explore the profile of I Caraballo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campinez M, Ferris C, de Paz M, Aguilar-de-Leyva A, Galbis J, Caraballo I
Int J Pharm
. 2015 Jan;
480(1-2):63-72.
PMID: 25579868
The main aim of this paper is the synthesis and characterization of a new linear functional biodegradable polythiourethane-d,l-1,4-dithiothreitol-hexamethylene diisocyanate [PTU(DTT-HMDI)]. The SeDeM diagram has been obtained to investigate its suitability...
2.
Contreras L, Melgoza L, Aguilar-de-Leyva A, Caraballo I
ScientificWorldJournal
. 2012 Aug;
2012:171292.
PMID: 22919292
Percolation theory has been applied in order to study the existence of critical points as well as the possibility to find a "combined percolation threshold" for ternary hydrophilic matrices prepared...
3.
Contreras L, Melgoza L, Villalobos R, Caraballo I
Int J Pharm
. 2009 Nov;
386(1-2):52-60.
PMID: 19900524
The purpose of the present work was to study the existence of critical points on the drug release and water uptake behaviour of ternary hydrophilic matrix tablets and to study...
4.
Fernandez-Espejo E, El Banoua F, Caraballo I, Galan B, Flores J
Rev Neurol
. 2003 Mar;
36(6):540-4.
PMID: 12652418
Aim And Method: Parkinson s disease is caused by the degeneration of dopaminergic neurons of substantia nigra projecting to striatum. Cellular substitution represents a potentially treatment once beneficial levodopa effects...
5.
Miranda A, Caraballo I, Millan M
Drug Dev Ind Pharm
. 2002 Jun;
28(4):413-22.
PMID: 12056534
A high-performance liquid chromatography (HPLC) assay has been developed for the determination of flutamide and its degradation products. Using this method, the influence of important formulation factors on the stability...
6.
Espejo E, Moraes J, El Banoua F, Flores J, Caraballo I
J Neurosci
. 2001 Dec;
21(24):9888-95.
PMID: 11739596
Intrabrain transplantation of chromaffin cell aggregates of the Zuckerkandl's organ, an extra-adrenal paraganglion that has never been tested for antiparkinsonian treatment, induced gradual improvement of functional deficits in parkinsonian rats....
7.
Melgoza L, Rabasco A, Sandoval H, Caraballo I
Eur J Pharm Sci
. 2001 Mar;
12(4):453-9.
PMID: 11231112
Percolation theory is a multidisciplinary theory that studies chaotic systems. It has been applied in the pharmaceutical field since 1987. Knowledge of the percolation threshold -- one of the most...
8.
Boza A, De la Cruz Y, Jordan G, Aleman A, Caraballo I
Drug Dev Ind Pharm
. 2001 Jan;
26(12):1303-7.
PMID: 11147132
The statistical optimization of sustained-release matrix tablets of lobenzarit disodium salt (LDS) was performed using the central composite experiment design 2(3) for three independent variables: the amount of polymer (Eudragit...
9.
Caraballo I, Millan M, Fini A, Rodriguez L, Cavallari C
J Control Release
. 2000 Dec;
69(3):345-55.
PMID: 11102675
Twenty matrix systems with different KCl content (as drug model, from 10 to 90% w/w) and Eudragit RS-PM (as inert excipient) were prepared using an ultrasound-assisted press and a traditional...
10.
Alvarez-Fuentes J, Rojas-Corrales M, Holgado M, Caraballo I, Mico J, Fernandez-Arevalo M
J Pharm Pharmacol
. 2000 Jun;
52(6):659-63.
PMID: 10875542
Naltrexone, a long-acting, orally effective, opioid antagonist which blocks opioid effects as well as the development of physical dependence, would appear to be a drug ideally suited to addiction treatment....